Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search
Fullscreen

For citations:


Bessonova T.O., Mukhortova P.A., Teryan R.A., Bagdasarov A.D., Musina N.Z. Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(1):17-34. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.173

Views PDF (Rus): 681


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)